5 amino 1mq dosage oral vs subcutaneous injectable 5-amino-1mq injection 5-amino-1mq subcutaneous injection dose 5-Amino-1MQ Peptide 5-amino-1mq subcutaneous injection dose 5-Amino-1MQ:

AOD-9604 10mg A modified C-terminal fragment of human growth hormone (residues 176-191 with an N-terminal tyrosine), supplied as 10 mg sterile lyophilized powder for in-vitro metabolic research

Quality Standards Across All Three All three are Janoshik-verified to 99% purity with mass-spec identity confirmation

Phase Split option Daily dose 50 mg morning + 50 mg midday Notes Some sources prefer split AM dosing because the plasma half-life is short (about 4 to 7 hours in rodent PK)

Full Growth Hormone : Research consistently shows that aod 9604 peptide produces fewer systemic side effects compared to full growth hormone administration, particularly regarding: Reduced joint pain and swelling Lower incidence of carpal tunnel syndrome Minimal impact on blood glucose levels Decreased risk of edema formation AOD 9604 vs